Abbott expects its new inexpensive point-of-care COVID-19 antigen test will allow for the detection of active COVID-19 infections on a “massive scale.”
On 26 August, the US Food and Drug Administration issued an emergency use authorization for Abbott’s BinaxNOW COVID-19 Ag...






